MX2007007211A - Procedimiento de fabricacion de salicilamidas n-sustituidas. - Google Patents

Procedimiento de fabricacion de salicilamidas n-sustituidas.

Info

Publication number
MX2007007211A
MX2007007211A MX2007007211A MX2007007211A MX2007007211A MX 2007007211 A MX2007007211 A MX 2007007211A MX 2007007211 A MX2007007211 A MX 2007007211A MX 2007007211 A MX2007007211 A MX 2007007211A MX 2007007211 A MX2007007211 A MX 2007007211A
Authority
MX
Mexico
Prior art keywords
manufacture process
substituted salicylamides
salicylamides
substituted
preparing
Prior art date
Application number
MX2007007211A
Other languages
English (en)
Inventor
Bernhard Riss
Ulrich Meier
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34090175&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2007007211(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MX2007007211A publication Critical patent/MX2007007211A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/60—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/24—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26—Two oxygen atoms, e.g. isatoic anhydride

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

La presente invencion se refiere a un metodo para la preparacion de salicilamidas N-sustituidas o sus derivados, y sus sales, hidratos y solvatos. En particular, la presente invencion se refiere a un metodo para la preparacion del acido N-(5-cloro-saliciloil)-8-amino-caprilico (5-CNAC) y su monohidrato disodico correspondiente.
MX2007007211A 2004-12-16 2005-12-14 Procedimiento de fabricacion de salicilamidas n-sustituidas. MX2007007211A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0427603.6A GB0427603D0 (en) 2004-12-16 2004-12-16 Organic compounds
PCT/EP2005/013454 WO2006063821A1 (en) 2004-12-16 2005-12-14 Manufacture process of n-substituted salicylamides

Publications (1)

Publication Number Publication Date
MX2007007211A true MX2007007211A (es) 2007-08-15

Family

ID=34090175

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007007211A MX2007007211A (es) 2004-12-16 2005-12-14 Procedimiento de fabricacion de salicilamidas n-sustituidas.

Country Status (24)

Country Link
US (1) US8461385B2 (es)
EP (2) EP2955171A1 (es)
JP (1) JP5224816B2 (es)
KR (1) KR101287233B1 (es)
CN (1) CN101080384B (es)
AR (1) AR055007A1 (es)
AU (1) AU2005315850B2 (es)
BR (1) BRPI0519327A2 (es)
CA (1) CA2587213C (es)
ES (1) ES2547349T3 (es)
GB (1) GB0427603D0 (es)
GT (1) GT200500353A (es)
IL (1) IL183366A0 (es)
MA (1) MA29092B1 (es)
MX (1) MX2007007211A (es)
NO (1) NO338969B1 (es)
PE (1) PE20060740A1 (es)
PL (1) PL1838664T3 (es)
PT (1) PT1838664E (es)
RU (1) RU2404158C2 (es)
TN (1) TNSN07229A1 (es)
TW (1) TW200635880A (es)
WO (1) WO2006063821A1 (es)
ZA (1) ZA200703826B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20070548A1 (es) * 2005-09-19 2007-07-12 Emisphere Tech Inc Formas cristalinas de la sal de di-sodio del acido n-(5-clorosaliciloil)-8-aminocaprilico
WO2009059188A1 (en) 2007-11-02 2009-05-07 Emisphere Technologies, Inc. Method of treating vitamin b12 deficiency
CN109473182B (zh) * 2018-11-12 2021-10-19 北京北排科技有限公司 一种基于深度信念网络的mbr膜透水率智能检测方法
CA3141383A1 (en) * 2019-05-20 2020-11-26 Lonza Guangzhou Pharmaceutical Ltd. Method for preparation of carsalam
CN115260116B (zh) * 2022-08-19 2024-04-12 株洲壹诺生物技术有限公司 8-(2-羟基苯甲酰胺基)辛酸钠及苯并噁嗪-2,4-二酮和8-溴辛酸乙酯的制法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2369591C (en) 1999-04-05 2011-06-14 Emisphere Technologies, Inc. Disodium salts, monohydrate, and ethanol solvates
BR0011928A (pt) * 1999-06-25 2002-04-09 Inst For Pharm Discovery Inc Composto, composição farmacêutica, uso de, um composto e métodos para o tratamento de complicações diabéticas, para o tratamento ou a prevenção do desenvolvimento de condições de doença associadas com velocidade de condução neuronial prejudicada e de neuropatia diabética
ES2386263T3 (es) 2000-03-21 2012-08-14 Emisphere Technologies, Inc. Método de preparación de salicilamidas alquiladas mediante un producto intermedio de dicarboxilato
WO2001092206A1 (en) 2000-06-02 2001-12-06 Emisphere Technologies, Inc. Method of preparing salicylamides
CN100482637C (zh) * 2000-06-29 2009-04-29 艾米斯菲尔技术有限公司 用于投递活性剂的化合物和组合物
US7495030B2 (en) * 2000-09-06 2009-02-24 Emisphere Technologies, Inc. (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
US7049283B2 (en) * 2000-12-06 2006-05-23 Novartis Ag Pharmaceutical compositions for the oral delivery of pharmacologically active agents
ES2412306T3 (es) * 2002-01-09 2013-07-11 Emisphere Technologies, Inc. Polimorfos de 4-((4-cloro-2-hidroxibenzoil)amino)butanoato de sodio
NZ534125A (en) 2002-02-20 2006-11-30 Emisphere Tech Inc A formulation comprising a GLP-1 compound and a delivery agent
US20050054557A1 (en) * 2002-05-09 2005-03-10 Goldberg Michael M. Compositions for delivering parathyroid hormone and calcitonin

Also Published As

Publication number Publication date
US8461385B2 (en) 2013-06-11
RU2007126972A (ru) 2009-01-27
GT200500353A (es) 2006-07-17
CA2587213C (en) 2015-05-19
RU2404158C2 (ru) 2010-11-20
CA2587213A1 (en) 2006-06-22
AU2005315850B2 (en) 2009-11-05
ZA200703826B (en) 2008-08-27
JP2008524142A (ja) 2008-07-10
IL183366A0 (en) 2007-09-20
AU2005315850A1 (en) 2006-06-22
KR20070086276A (ko) 2007-08-27
GB0427603D0 (en) 2005-01-19
EP1838664B1 (en) 2015-07-15
EP1838664A1 (en) 2007-10-03
PE20060740A1 (es) 2006-09-04
AR055007A1 (es) 2007-08-01
NO20073548L (no) 2007-09-17
PT1838664E (pt) 2015-10-16
JP5224816B2 (ja) 2013-07-03
TW200635880A (en) 2006-10-16
EP2955171A1 (en) 2015-12-16
WO2006063821A1 (en) 2006-06-22
CN101080384A (zh) 2007-11-28
KR101287233B1 (ko) 2013-07-17
PL1838664T3 (pl) 2016-04-29
MA29092B1 (fr) 2007-12-03
NO338969B1 (no) 2016-11-07
US20090253811A1 (en) 2009-10-08
TNSN07229A1 (en) 2008-11-21
BRPI0519327A2 (pt) 2009-01-13
ES2547349T3 (es) 2015-10-05
CN101080384B (zh) 2011-06-15

Similar Documents

Publication Publication Date Title
ECSP095220A (es) Derivados de n-fenil-2-pirimidin-amina
DOP2001000238A (es) Proceso para la fabricacion de acidos n-aril-antrani- licos y sus derivados (process for making-aryl- anthranilic acids and their)
IS6069A (is) N-cýanómetýlamíð sem próteasalatar
MX2007007273A (es) Procedimiento de fabricacion de salicilamidas n-sustituidas.
IS2582B (is) Afleiður af N-(arýlsúlfónýl)beta-amínósýrum sem samanstanda af setnum amínómetýl hópi, aðferð til framleiðslu á afleiðum og lyfjafræðilegar samsetningar sem innihalda þær
TNSN07229A1 (en) Manufacture process of n-substituted salicylamides
GB0403792D0 (en) Enhancing solubility of iron amino acid chelates and iron proteinates
HN2003000038A (es) Esteres hidroxamato de acido n-(4-fenil-sustituido)-antranilico
BRPI0410861A (pt) métodos e composições para a produção de aminoácidos
WO2001068645A3 (en) N-cyanomethylcarboxamides and their use as protease inhibitors
JO3684B1 (ar) صور متبلرة من الملح ثنائي الصوديوم لحمض n-(5-كلورو ساليسلويل)-8-امينو كابريليك
MXPA05003355A (es) Composicion farmaceutica que comprende semihidrato de metansulfonato de sibutramina cristalino.
RS63804A (en) Stable salts of o-acetylsalicylic acid containing basic amino acids ii
NO20025124D0 (no) Metode
ZA202211321B (en) N,n'-guanidinodiacetic acid
RS20050272A (en) Pharmaceutical composition comprising crystalline sibutramine methanesulfonate hemihydrate
PL1845966T3 (pl) Farmaceutyczny preparat do zastosowania w leczeniu lub profilaktyce chorób nowotworowych
BRPI0406970A (pt) Modificação cristalina de um complexo de manganês
RS20060049A (en) Novel n-substituted indolyl-3-glycoxylic acid amides, use thereof as a medicament and method for the production thereof

Legal Events

Date Code Title Description
FG Grant or registration